Most Read Articles
Jairia Dela Cruz, one month ago
Statins appear to have a dose-dependent association with the risk of tuberculosis (TB), with a nationwide population-based study showing that statin users have 47 percent lower incidence of TB compared with nonusers.
one year ago
Long-term pegvisomant treatment enhances cardiac and respiratory comorbidities in acromegalic patients based on a retrospective single-centre study.
one year ago
Ampicillin/sulbactam is an effective first-line therapy among elderly patients with Nursing- and Healthcare- associated Pneumonia (NHCAP), as observed in a retrospective analysis.
Audrey Abella, 2 months ago
Fixed-dose combinations of long-acting β2-agonist (LABA) and muscarinic antagonist (LAMA) offered superior efficacy and comparable safety to LAMA or LABA/inhaled corticosteroid (ICS), the two most commonly prescribed first-line treatments for stable moderate-to-very-severe chronic obstructive pulmonary disease (COPD), according to a meta-analysis.

New Product Highlight - Nicorette

2 years ago
NICORETTE – Nicotine 10 mg, 15 mg, 25 mg Patch
• Week 1 abstinence is an important predictor of long-term success1,3
• Significantly more smokers were abstinent during week 1 with Nicorette patch 25 mg/16 hr compared to our previous patch programme (p<0.01)2
• 94% more effective than placebo at helping smokers to quit at 12 weeks (p<0.001)1,5
• 44% more effective at helping smokers quit compared with our previous patch programme at 12 weeks (p<0.005)1,4
• 16-hr patch is well tolerated with a good safety profile6

References:
1. Tønnesen P et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur Resp J 1999;13:238-246
2. Data on file – CEASE 2.
3. Stapleton JA et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995;90:31–42.
4. Data on file – CEASE 3.
5. Data on file - CEASE 4.
6. Nicorette Invisi Transdermal Patch Package Insert 2014

Further information available in Section 18b, New in This Issue and mims.com. Full prescribing information is available upon request.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, one month ago
Statins appear to have a dose-dependent association with the risk of tuberculosis (TB), with a nationwide population-based study showing that statin users have 47 percent lower incidence of TB compared with nonusers.
one year ago
Long-term pegvisomant treatment enhances cardiac and respiratory comorbidities in acromegalic patients based on a retrospective single-centre study.
one year ago
Ampicillin/sulbactam is an effective first-line therapy among elderly patients with Nursing- and Healthcare- associated Pneumonia (NHCAP), as observed in a retrospective analysis.
Audrey Abella, 2 months ago
Fixed-dose combinations of long-acting β2-agonist (LABA) and muscarinic antagonist (LAMA) offered superior efficacy and comparable safety to LAMA or LABA/inhaled corticosteroid (ICS), the two most commonly prescribed first-line treatments for stable moderate-to-very-severe chronic obstructive pulmonary disease (COPD), according to a meta-analysis.